Isoniazid is approved for latent and active tuberculous infections; for the latter, it is used in combination with other tuberculosis medications to prevent the development of drug resistance.
For the latter, it must be used in combination with other tuberculosis medications to prevent the development of drug resistance. Isoniazid is approved for latent and active tuberculous infections.
Isoniazid is approved for latent and active tuberculous infections. For the latter, it must be used in combination with other tuberculosis medications to prevent the development of drug resistance.
Isoniazid is approved for latent and active tuberculous infections. For the latter, it must be used in combination with other tuberculosis medications to prevent the development of drug resistance.